DYNC1LI2
Basic information
Region (hg38): 16:66720893-66751609
Previous symbols: [ "DNCLI2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DYNC1LI2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 18 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 1 | 0 |
Variants in DYNC1LI2
This is a list of pathogenic ClinVar variants found in the DYNC1LI2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-66723771-C-T | not specified | Uncertain significance (Jun 10, 2024) | ||
16-66727724-C-T | not specified | Uncertain significance (Jan 12, 2024) | ||
16-66727726-G-A | not specified | Uncertain significance (May 15, 2024) | ||
16-66728211-G-A | not specified | Uncertain significance (Apr 27, 2024) | ||
16-66729090-C-T | not specified | Uncertain significance (Jun 30, 2022) | ||
16-66730132-C-A | not specified | Uncertain significance (Dec 07, 2023) | ||
16-66730174-A-G | not specified | Uncertain significance (Oct 06, 2024) | ||
16-66732391-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
16-66732430-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
16-66734219-C-A | not specified | Uncertain significance (Feb 27, 2023) | ||
16-66734219-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
16-66736088-A-G | not specified | Uncertain significance (Mar 18, 2024) | ||
16-66736215-G-A | not specified | Uncertain significance (Jan 06, 2023) | ||
16-66742498-G-A | not specified | Uncertain significance (Nov 24, 2024) | ||
16-66742561-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
16-66742603-C-A | not specified | Uncertain significance (Nov 12, 2021) | ||
16-66742653-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
16-66742660-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
16-66749220-C-T | not specified | Uncertain significance (Nov 02, 2023) | ||
16-66749221-T-C | not specified | Uncertain significance (Feb 21, 2024) | ||
16-66749230-G-C | not specified | Uncertain significance (Sep 08, 2024) | ||
16-66749273-T-C | Likely benign (Sep 01, 2022) | |||
16-66751311-C-T | not specified | Uncertain significance (Jul 30, 2023) | ||
16-66751352-G-A | Likely benign (Sep 01, 2022) | |||
16-66751515-G-A | not specified | Uncertain significance (May 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DYNC1LI2 | protein_coding | protein_coding | ENST00000258198 | 13 | 30906 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.983 | 0.0165 | 125743 | 0 | 4 | 125747 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.89 | 186 | 274 | 0.678 | 0.0000142 | 3199 |
Missense in Polyphen | 55 | 105.4 | 0.52182 | 1292 | ||
Synonymous | -0.304 | 114 | 110 | 1.04 | 0.00000633 | 974 |
Loss of Function | 4.15 | 3 | 25.7 | 0.117 | 0.00000124 | 324 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000681 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in binding dynein to membranous organelles or chromosomes.;
- Pathway
- Salmonella infection - Homo sapiens (human);Phagosome - Homo sapiens (human);Vasopressin-regulated water reabsorption - Homo sapiens (human);Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal;Amplification of signal from the kinetochores;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RHO GTPases Activate Formins;RHO GTPase Effectors;Signaling by Rho GTPases;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPI-independent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Mitotic Prometaphase;COPI-mediated anterograde transport;Separation of Sister Chromatids;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Resolution of Sister Chromatid Cohesion;ER to Golgi Anterograde Transport;Cell Cycle, Mitotic;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.0932
Intolerance Scores
- loftool
- 0.254
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 14.97
Haploinsufficiency Scores
- pHI
- 0.345
- hipred
- Y
- hipred_score
- 0.696
- ghis
- 0.597
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.929
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dync1li2
- Phenotype
Zebrafish Information Network
- Gene name
- dync1li2
- Affected structure
- cell
- Phenotype tag
- abnormal
- Phenotype quality
- structure
Gene ontology
- Biological process
- microtubule cytoskeleton organization;endoplasmic reticulum to Golgi vesicle-mediated transport;microtubule-based movement;antigen processing and presentation of exogenous peptide antigen via MHC class II;protein homooligomerization;centrosome localization;cellular response to nerve growth factor stimulus
- Cellular component
- kinetochore;lysosome;late endosome;centrosome;cytosol;cytoplasmic dynein complex;microtubule;membrane
- Molecular function
- microtubule motor activity;ATP binding;dynein heavy chain binding